Stock 603229 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Ausun Pharmaceutical Co., Ltd.

Equities

603229

CNE100002XK2

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
10.49 CNY +0.87% Intraday chart for Zhejiang Ausun Pharmaceutical Co., Ltd. +9.84% -20.59%
26/04 Zhejiang Ausun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
26/04 Zhejiang Ausun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Zhejiang Ausun Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of specialty bulk pharmaceutical chemicals (BPCs) and pharmaceutical intermediates. The Company's main products include bimatoprost, latanoprost, latanoprostene bunod, entecavir, selectfluor and other intermediates. The Company is also involved in the provision of customized production, as well as research and development services to customers through its subsidiaries.

Number of employees: 1,129

Sales per Business

CNY in Million2021Weight2022Weight Delta
Cardiovascular and Cerebrovascular
25.0 %
34 5.9 % 191 25.0 % +468.48%
Liver Diseases
23.6 %
157 27.6 % 180 23.6 % +14.85%
Nervous System
16.1 %
90 15.9 % 123 16.1 % +36.08%
Antibacterial
11.0 %
115 20.1 % 84 11.0 % -26.94%
Gout
9.4 %
46 8.1 % 72 9.4 % +54.76%
Other
7.2 %
55 9.7 % 55 7.2 % -0.45%
Technical Services
4.2 %
33 5.7 % 32 4.2 % -2.62%
Prostaglandin
2.5 %
14 2.5 % 19 2.5 % +35.50%
Respiratory System
0.5 %
10 1.8 % 4 0.5 % -60.19%
Anti-tumor
0.3 %
15 2.6 % 3 0.3 % -82.63%
High-end Fluorine
0.3 %
1 0.2 % 2 0.3 % +137.25%

Sales per region

CNY in Million2021Weight2022Weight Delta
International
57.3 %
306 53.7 % 438 57.3 % +43.36%
China
42.7 %
264 46.3 % 326 42.7 % +23.59%

Managers

Managers TitleAgeSince
Zhi Guo Zheng CEO
 Chief Executive Officer 53 15/14/15
Ding Min Zhu DFI
 Director of Finance/CFO 57 02/21/02
Hua Dong Zhang BRD
 Director/Board Member 47 14/14/14
Tuan Tuan Wang IRC
 Investor Relations Contact - -
Xiao Chen Ying SEC
 Corporate Secretary 43 25/21/25
Yu Zhong PRN
 Corporate Officer/Principal 62 15/20/15

Members of the board

Members of the board TitleAgeSince
Fei Chen BRD
 Director/Board Member 44 08/15/08
Zhi Guo Zheng CEO
 Chief Executive Officer 53 15/14/15
Zhi Shu Yang BRD
 Director/Board Member 58 13/20/13
Bing Liu FOU
 Founder 55 14/14/14
Hua Dong Zhang BRD
 Director/Board Member 47 14/14/14
Shi Lan Zheng BRD
 Director/Board Member 49 14/14/14
Hai Yan Xu CHM
 Chairman 42 25/15/25
Yu Liu BRD
 Director/Board Member 42 15/14/15
Fu Li Zhang BRD
 Director/Board Member 56 13/17/13
He Min Zhu BRD
 Director/Board Member 37 01/13/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 593,069,389 237,411,769 ( 40.03 %) 0 40.03 %

Shareholders

NameEquities%Valuation
Zhi Guo Zheng
50.64 %
300,309,787 50.64 % 422 M ¥
Shi Lan Zheng
2.788 %
16,536,929 2.788 % 23 M ¥
Bing Liu
1.123 %
6,662,326 1.123 % 9 M ¥
Hua Dong Zhang
0.4647 %
2,756,074 0.4647 % 4 M ¥
Yinhua Fund Management Co., Ltd.
0.4009 %
2,377,889 0.4009 % 3 M ¥
GF Fund Management Co., Ltd.
0.1964 %
1,164,934 0.1964 % 2 M ¥
Penghua Fund Management Co., Ltd.
0.1805 %
1,070,720 0.1805 % 2 M ¥
Caitong Fund Management Co., Ltd.
0.1430 %
847,913 0.1430 % 1 M ¥
China Merchants Fund Management Co., Ltd.
0.1039 %
616,115 0.1039 % 866 104 ¥
CCB Principal Asset Management Co., Ltd.
0.0944 %
559,675 0.0944 % 786 763 ¥

Company contact information

Zhejiang Ausun Pharmaceutical Co., Ltd.

5 Donghai Fourth Avenue Linhai Park

317016, Taizhou

+

http://www.ausunpharm.com
address Zhejiang Ausun Pharmaceutical Co., Ltd.(603229)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Zhejiang Ausun Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.49
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Stock Zhejiang Ausun Pharmaceutical Co., Ltd.
-20.59% 859M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.13% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.89% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.31% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.60% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.23% 231B
NOVARTIS AG Stock Novartis AG
+5.13% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-8.96% 195B
AMGEN INC. Stock Amgen Inc.
-4.91% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603229 Stock
  4. Company Zhejiang Ausun Pharmaceutical Co., Ltd.